🇺🇸 FDA
Patent

US 9931419

Methods and compositions for liposomal formulation of antigens and uses thereof

granted A61KA61K2039/55555A61K2039/55572

Quick answer

US patent 9931419 (Methods and compositions for liposomal formulation of antigens and uses thereof) held by The Regents of the University of California expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/55555, A61K2039/55572, A61K2039/60, A61K2039/6018